Effectiveness of double bolus alteplase in the treatment of acute myocardial infarction

This publication has 14 references indexed in Scilit:

• A pilot study of the efficacy and safety of bolus administration of alteplase in acute myocardial infarction.
  Heart, 1991
• GISSI-2 and the heparin controversy
  The Lancet, 1990
• Effectiveness of multiple bolus administration of tissue-type plasminogen activator in acute myocardial infarction
  The American Journal of Cardiology, 1990
• Enhancing thrombolytic efficacy by means of “front-loaded” administration of tissue plasminogen activator
  Journal of the American College of Cardiology, 1989
• Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator
  Journal of the American College of Cardiology, 1989
• BOLUS ALTEPLASE
  The Lancet, 1989
• Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.
  BMJ, 1988
• Thrombolysis in myocardial infarction (TIMI): Comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator
  Journal of the American College of Cardiology, 1987
• The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: Influence of dosage regimens in rabrits
  Thrombosis Research, 1985
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985